Essex LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Essex LLC's PFE Position: Q2 2026 in Review
Essex LLC increased its Pfizer (PFE) stake by 8.7% in Q2 2026, buying an estimated $122K and bringing the position to 58,322 shares worth $1.4M. The position accounts for 0.21% of the portfolio, ranked #74.
Essex LLC first reported a position in PFE in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.44M in Q2 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Essex LLC held 58,322 shares of Pfizer worth $1.4M as of Q2 2026.
- Essex LLC bought 4,657 Pfizer shares in Q2 2026, an estimated $122K.
- Pfizer made up 0.21% of Essex LLC's portfolio in Q2 2026, its #74 holding.
- Essex LLC first reported a position in Pfizer in Q3 2021 and has held it in 20 quarters since.
- Essex LLC's Pfizer position peaked at $3.44M in Q2 2022.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Essex LLC's 13F filing for Q2 2026, filed 24 Jul 2026.